Ophthalmology
Transforming the treatment of serious, vision-threatening diseases
Millions of people around the world are impacted by vision-threatening conditions, which can dramatically affect a person’s independence and quality of life. For more than 20 years, Regeneron has been relentlessly pursuing groundbreaking innovations in eye care science to help make a meaningful difference in their lives.
Our transformative scientific research began with a focus on understanding how blocking the growth of new blood vessels (angiogenesis) can decrease the ability of fluid to pass through blood vessels in the eye. Our research has since brought fundamental change to the treatment paradigm for serious eye diseases, including wet age-related macular degeneration, diabetic retinopathy, diabetic macular edema, macular edema following retinal vein occlusion and retinopathy of prematurity. Fortunately, patients who have been diagnosed with these serious eye diseases now have options to treat them.
Our ongoing commitment to researching retinal diseases
Our deep expertise in angiogenesis now serves as our foundation for ongoing innovation and fuels our ambition to develop new solutions for patients and eye care. Our robust and diverse research and development program in ophthalmology includes efforts to potentially address many other serious eye diseases, including geographic atrophy, glaucoma and certain inherited retinal diseases. In addition to the proprietary Trap technology that was the basis for our leading therapeutic, we use monoclonal antibodies and cutting-edge modalities like RNA interference and gene therapy as the basis for new potential medicines.
Our perspectives on clinical innovation in ophthalmology
With our decades of research experience in ophthalmology, we have developed unique and valuable insights that are helping shape our work today. Hear from several of our ophthalmology experts as they share their perspectives on Regeneron’s scientific approach, lessons learned and our commitment to continued innovation.
Select a Video
Eye on the Experts: Insights from 20 Years in Ophthalmology Research
Listen to Regeneron Ophthalmology experts talk about our impact and the critical need to collaborate with the retinal community from the beginning to create meaningful change.
Eye on the Experts: Lessons Learned in Ophthalmology Clinical Trials
Hear about the challenges we’ve faced and the lessons we’ve learned that are helping inform and improve our approach to research and development today.
Eye on the Experts: Building on Legacy to Drive Innovation
Watch Regeneron Ophthalmology leaders discuss how we’re leveraging our expertise in angiogenesis to keep innovating for patients with vision-threatening conditions.
Video Title
Video Description